Transcranial Magnetic Stimulation in Misophonia
A Transcranial Magnetic Stimulation Approach to Treat Misophonia
Icahn School of Medicine at Mount Sinai
60 participants
Sep 2, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of the project is to assess the efficacy of parietal transcranial magnetic stimulation in misophonia. N=60 participants will undergo two transcranial magnetic stimulation sessions: one inhibitory and another excitatory. During both sessions, the parietal region will be stimulated. Participants will perform computerized tasks immediately before and after the stimulation, while EEG, heart rate, and skin temperature will be recorded. These recordings will be used to assess if TMS can be used to improve tolerance to misophonia triggers.
Eligibility
Inclusion Criteria3
- Hypersensitive to presence of a specific sound, which may be accompanied by irritation, anger/outbursts, or fear.
- Must be between the ages of 18 - 55.
- Must be fluent in English since the study's instructions, surveys, and tasks will be in English.
Exclusion Criteria7
- Axis I Psychiatric condition, past or present, as defined in DSM-V.
- Disability or medical condition that prohibits completion of study. Participants must be able to complete all study procedures to ensure optimal conditions for data analysis.
- Central Nervous System (CNS) disease, such as history of brain abnormalities (e.g., neoplasms, subarachnoid cysts), cerebrovascular disease, infectious disease (e.g., abscess), or other neurological diseases, history of head trauma (defined as loss of consciousness>3 min), or history of seizures without a resolved etiology. CNS disease and drugs that act in the peripheral or central nervous system are likely to have effects on patterns of neural activity.
- Recent or regular use of psychotropic medication (e.g., amitriptyline for migraines).
- Recent use of drugs of abuse.
- Presence of any mental implants in the head.
- Pregnant or lactating.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Transcranial Magnetic Stimulation (TMS) is an FDA-approved non-invasive brain stimulation technology. It is currently used for treating depression. Applications to other disorders such as OCD and anxiety using TMS are currently under investigation. TMS will be administered for 25 minutes.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06960083